1-stearoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl-sn-glycero-3-phosphate

Metabolite details

Identifier

SFHGEOGVGJYLEK-USQBYQOHSA-N

InChI Key

SFHGEOGVGJYLEK-USQBYQOHSA-N

IUPAC name

(2R)-3-(octadecanoyloxy)-1-(phosphonooxy)propan-2-yl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate

Preferred name

1-stearoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoyl-sn-glycero-3-phosphate

INN name

—

Synonym

(2R)-1-(phosphonooxy)-3-(stearoyloxy)propan-2-yl (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate

ChEBI

CHEBI:77258

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Effect of L-carnitine administration on lipid and metabolite content in sheep infraspinatus muscle after tendon release
• Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
• Lipidomic Changes in the Liver of Beagle Dogs Associated with Toxocara canis Infection

Observed in differential profiles

• Control_16.6_months_vs_Treatment_16.6_months
• Control_vs_nsPEF_7_day
• Control_12h_vs_Toxocara canis_12h